Vasodilator therapy in congestive heart failure. 1982

P J Bower

UI MeSH Term Description Entries
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

P J Bower
October 1981, Annals of the Academy of Medicine, Singapore,
P J Bower
January 1980, Duodecim; laaketieteellinen aikakauskirja,
P J Bower
November 1986, The New England journal of medicine,
P J Bower
January 1981, Cardiovascular clinics,
P J Bower
January 1980, Advances in internal medicine,
P J Bower
April 1980, The Journal of pediatrics,
P J Bower
September 1977, Deutsche medizinische Wochenschrift (1946),
P J Bower
November 1982, Current problems in cardiology,
Copied contents to your clipboard!